NeuroPace (NPCE) Gross Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
NeuroPace (NPCE) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 128.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 147.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -3.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 448.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 305.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -6.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 635.00 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 391.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 69.00 |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | -31.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.00 |
| Mar 31, 2026 | 479.00 |
| Dec 31, 2025 | 198.00 |
| Sep 30, 2025 | 417.00 |
| Jun 30, 2025 | 974.00 |
| Mar 31, 2025 | 337.00 |
| Dec 31, 2024 | 21.00 |
| Sep 30, 2024 | -125.00 |
| Jun 30, 2024 | 89.00 |
| Mar 31, 2024 | 195.00 |
| Dec 31, 2023 | 637.00 |
| Sep 30, 2023 | 308.00 |
| Jun 30, 2023 | -68.00 |
| Mar 31, 2023 | -94.00 |
| Dec 31, 2022 | -461.00 |
| Sep 30, 2022 | -122.00 |
| Jun 30, 2022 | -91.00 |
| Mar 31, 2022 | -310.00 |
| Dec 31, 2021 | -300.00 |
| Sep 30, 2021 | -237.00 |